About Enhancer
| Enhancer ID: | E_01_0788 |
| Species: | human |
| Position : | chr18:58668913-58670913   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Oscc, colorectal, hepatocellular carcinoma |
| Pubmed ID: | 30042166 |
| Enhancer experiment: | QRT PCR, Western blot, chromatin immunoprecipitation, RNA immunoprecipitation (RIP), statistical analysis, flow cytometry |
| Enhancer experiment description: | Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues. |
About Target gene
| Target gene : | MALT1,CRNDE |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues.;Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues.;Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues. |
About TF
| TF name : | KLF2(LKLF) |
| TF experiment: | qRT-PCR,Western blot,Chromatin immunoprecipitation,RNA immunoprecipitation (RIP),????,????? |
| TF experiment description: | Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues.;Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues.;Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues. |
About Function
| Enhancer function : | Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Besides, it was also found out that KLF2 and p21 were down-regulated in glioma tissues. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| KLF2 | Hs_White_fat_cell_differentiation_WP3946_90940 | wikipathways | 30 |
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene